Thursday 7 April 2022 is World Health Day. This year’s motto is ‘Our planet, our health’. Are we able to reimagine a world where clean air, water and food are available to all? Where economies are focused on health and well-being? Where cities are liveable and people have control over their health and the health of the…
From Cancer Australia – Important information for cancer patients regarding COVID Managing your cancer care in the context of COVID-19 ‘Managing your cancer care in the context of COVID-19’ is a new online resource developed to help people being treated for cancer who test positive to COVID-19 can make decisions with their treating team…
New and updated information from Cancer Council Understanding Chronic Leukaemia April 2022 – Available now. This guide is for people affected by chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML).
Prof Dorothy Keefe reappointed as CEO of Cancer Australia The Minister for Health, Greg Hunt has announced that Professor Dorothy Keefe, PSM MD, has been re-appointed as Cancer Australia Chief Executive Officer for a further three years. Cancer Voices congratulates Dorothy Keefe on her reappointment and looks forward to our continued collaboration with her and…
Cancer Voices involvement in the National Pancreatic Cancer Roadmap CVN member Gino Iori was nominated by Cancer Voices for the Cancer Australia Pancreatic Roadmap steering committee in late 2020. Gino brings a carer’s perspective to all his consumer representative work. His brother passed away from pancreatic cancer in 2011 and following CIR training in 2014…
Message from the National Pancreatic Cancer Roadmap key stakeholders This video provides an overview of the National Pancreatic Cancer Roadmap by Cancer Australia CEO Professor Dorothy Keefe and key stakeholders. They outline the impact of pancreatic cancer and the key priorities this transformative pathway is designed to address. Watch the video here.
National Pancreatic Roadmap launched The Australian Government has launched the National Pancreatic Cancer Roadmap (Roadmap) and has committed $20.3 million to support improved outcomes and survival for Australians affected by pancreatic cancer. The National Pancreatic Cancer Roadmap identifies 33 key priority areas and 60 strategies for collective action over the next five years to 2027.…
National Medicines Policy Review deferred The Federal Government has listened to stakeholders including patient groups, industry and professional organisations and has now deferred the finalisation of the National Medicines Policy Review (NMPR) until after the Federal election. The National Medicines Policy has been in place since 2000 and this is the first review. The review…
1 in 2 of us will get cancer in our lifetime. But all of us can support the research that will beat it. Everyone has a part to play and every part supports life-saving research. So play your part, and together we will beat cancer.
Sally Crossing AM Award 2022: Celebrating advances in breast cancer research The 2022 Sally Crossing AM Award for an Outstanding outcome in cancer research has been awarded to Professor Elgene Lim for his Celebrating advances in breast cancer research. ‘The award recognises the outcomes achieved by Professor Lim arising from research previously funded by Cancer…
Updated information from Cancer Council Understanding Prostate Cancer March 2022 This revised guide is for people affected by a diagnosis of prostate cancer. Printed booklets can be ordered using the Publications Order Form on the website.
Updated information from Cancer Council Understanding Pancreatic Cancer March 2022. This revised guide is for people affected by pancreatic cancer. It focuses on pancreatic adenocarcinoma, which is the most common type of pancreatic cancer. Printed booklets can be ordered using the Publications Order Form on the website.
Updated information from Cancer Council Understanding Bladder Cancer February 2022. This revised guide is for people affected by bladder cancer. Printed booklets can be ordered using the Publications Order Form on the website.
Cancer Voices NSW has a new Constitution, and Executive Committee Charter Cancer Voices NSW has a new Constitution following the unanimous decision at the Annual General Meeting on 25 February 2022. You can read the new Constitution here. New legislation for the operation of incorporated associations commenced in NSW in 2009 with the introduction of…
Cancer Voices NSW AGM Cancer Voices NSW Annual General Meeting was held online for the second year on 25 February via Zoom. Whilst we miss meeting face to face, the online format enabled our regional EC members to attend, and we also welcomed some other CVN members. We thank them for taking the time to…
New Secretary of NSW Health – Congratulations Ms Susan Pearce NSW Health Deputy Secretary Susan Pearce will take over as the new department head following the departure of Elizabeth Koff. Susan Pearce Ms Pearce has been deputy for the past six years and has led the operational aspects of NSW Health’s COVID-19 response, including its testing clinics…
Cancer Care – Do cancer survivors get enough care? On 3 February 2022 Flinders University Fearless Conversations series featured a discussion on the issues surrounding the needs of cancer survivors, and how health services can better aid survivors of a disease that will directly affect one in two Australians by the age of 85. Facilitated…
World Cancer Day – UNSW hosted a webinar The Cancer Clinical Advisory Group UNSW hosted a webinar on World Cancer Day. The webinar featured presentations from Dr Ben Smith and A/Prof Winston Liauw followed by a consumer led panel discussion facilitated by Kathryn Leaney and Murray McLachlan focusing on equity in cancer care.
2nd Patient Voice Podcast launched Jessica Bean chats to Lisa Briggs Hear patient advocate, Lisa Briggs, a mother of two who was diagnosed with a rare form of lung cancer in 2014, chats to patient advocate and PVI Chair, Jessica Bean. Following her diagnosis, Lisa has advocated for reform in the health sector. She generously shares…
Understanding Clinical Trials and Research Guide January 2022 New and updated information from CCNSW Understanding Clinical Trials and Research January 2022 This guide is for people affected by cancer who are considering joining a clinical trial as part of their treatment. It also provides an overview of cancer research in Australia but has a particular…
New CEO of the National Breast Cancer Foundation announced Prof Helen Zorbas AO, Chair of the National Breast Cancer Foundation (NBCF), has announced the appointment of Assoc Prof Cleola Anderiesz as the new CEO of NBCF. A/P Cleola Anderiesz has over 20 years of experience across the research, academic, not-for-profit and public sectors with her…
IMPORTANT INFORMATION FOR CANCER PATIENTS From Cancer Australia Crucial information for multicultural communities about COVID-19 vaccines and cancer Your questions about COVID-19 vaccines and cancer answered in your language To support multicultural communities with evidence-based information about COVID-19 vaccines and cancer, Cancer Australia has released Frequently Asked Questions (FAQs) translated into 10 languages specifically for…
The inaugural Thoracic Oncology Group of Australasia (TOGA) ASM 2021 22-23 July – Equity in innovation in Multidisciplinary lung cancer care Lung cancer screening, neoadjuvant treatment, the future influence of biomarker-driven treatments for lung cancer, the challenges of overcoming inequities in quality care, thought-provoking multi-disciplinary discussion, innovative clinical research and clinical trial concept development workshops.…
The Australian Clinical Trials Alliance (ACTA), together with event partners MTPConnect, Bellberry and Medicines Australia, and supporters, the National Health and Medical Research Centre (NHMRC), CT:IQ (Clinical Trials: Thinking Smarter), Medical Technology Association of Australia (MTAA), and Research Australia, hosted the Clinical Trials 2021 National Tribute & Awards Ceremony on 20 May 2021 to mark…